XML 43 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Research and Development Activity (Details)
3 Months Ended 12 Months Ended
Jun. 26, 2025
USD ($)
Mar. 31, 2025
USD ($)
Mar. 31, 2025
GBP (£)
Dec. 31, 2024
USD ($)
Research and Development Activity [Line Items]        
Royalty on net sales of percentage   5.00%    
License agreement   $ 300,000 £ 250,000  
Milestone payments   7,800,000 £ 6,000,000  
Accounts payable and accrued liabilities   7,198,000   $ 6,539,000
Percentage of licensor royalty patent grant       1.00%
Accounts payable and accrued liabilities   $ 25,000   $ 25,000
Percentage of net sales to pay royalties   2.50% 2.50%  
Agreement expiry period, description   The PITT Agreement expires upon the earlier of: (i) expiration of the last claim of the Patent Rights (as defined in the PITT Agreement) forming the subject matter of the PITT Agreement; or (ii) the date that is 20 years from the effective date of the agreement (June 26, 2037). The PITT Agreement expires upon the earlier of: (i) expiration of the last claim of the Patent Rights (as defined in the PITT Agreement) forming the subject matter of the PITT Agreement; or (ii) the date that is 20 years from the effective date of the agreement (June 26, 2037).  
Forecast [Member]        
Research and Development Activity [Line Items]        
Maintenance fees $ 25,000      
Great Ormond Street Hospital [Member]        
Research and Development Activity [Line Items]        
Accounts payable and accrued liabilities   $ 300,000   0
Australia [Member]        
Research and Development Activity [Line Items]        
Research and development tax credit receivable   $ 1,283,000   $ 1,181,000